This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
K2M Group (KTWO) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
K2M Group (KTWO) delivered earnings and revenue surprises of -125.00% and -0.20%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Will K2M Group (KTWO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
K2M Group (KTWO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News For Aug 31, 2018
by Zacks Equity Research
Wall Street ended its four day winning streak on Thursday as trade related conflicts between the United States and China reared its head again.
Stryker (SYK) to Acquire K2M Group, Fortify Spine Division
by Zacks Equity Research
Post the acquisition, Stryker (SYK) will leverage on K2M Group's (KTWO) complex spine and minimally invasive solutions.
K2M Group (KTWO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
K2M Group (KTWO) delivered earnings and revenue surprises of -19.05% and 3.78%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT
by Zacks Equity Research
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT
5 MedTech Stocks for Stellar Returns in Q3
by Zacks Equity Research
Here we take a sneak peek into two burning issues that are likely to impact the quarterly numbers in the MedTech fraternity.
Company News For Oct 10, 2017
by Zacks Equity Research
Companies in the news are: MZOR,CGEN,KTWO,AXTA
K2M Group Holdings (KTWO) in Focus: Stock Up 6.3%
by Zacks Equity Research
K2M Group Holdings, Inc. (KTWO) saw its shares rise above 6% in the last trading session.
4 Medical Instrument Stocks Poised for Earnings Beats in Q2
by Zacks Equity Research
Rising demand for better healthcare at an affordable cost will be a key growth driver for medical instrument suppliers in 2015.